NVAXNOVAVAX INC

Nasdaq novavax.com


$ 12.20 $ 0.03 (0.25 %)    

Wednesday, 14-Aug-2024 15:59:59 EDT
QQQ $ 463.74 $ 0.15 (0.03 %)
DIA $ 400.12 $ 2.30 (0.58 %)
SPY $ 543.85 $ 1.71 (0.32 %)
TLT $ 97.88 $ 0.61 (0.63 %)
GLD $ 226.19 $ -1.86 (-0.82 %)
$ 12.19
$ 12.20 x 200
-- x --
-- - --
$ 3.53 - $ 23.86
4,701,764
na
2.02B
$ 0.39
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 05-10-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-09-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 02-28-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 03-01-2022 12-31-2021 10-K
12 11-04-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-10-2021 03-31-2021 10-Q
15 03-01-2021 12-31-2020 10-K
16 11-10-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-11-2020 03-31-2020 10-Q
19 03-11-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-07-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 03-18-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-09-2018 03-31-2018 10-Q
27 03-14-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-08-2017 06-30-2017 10-Q
30 05-08-2017 03-31-2017 10-Q
31 02-27-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-09-2016 06-30-2016 10-Q
34 05-05-2016 03-31-2016 10-Q
35 02-29-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 08-10-2015 06-30-2015 10-Q
38 05-07-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-06-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 b-riley-securities-reiterates-buy-on-novavax-lowers-price-target-to-23

B. Riley Securities analyst Mayank Mamtani reiterates Novavax (NASDAQ:NVAX) with a Buy and lowers the price target from $25 ...

 jp-morgan-maintains-underweight-on-novavax-raises-price-target-to-9

JP Morgan analyst Eric Joseph maintains Novavax (NASDAQ:NVAX) with a Underweight and raises the price target from $8 to $9.

 covid-19-vaccine-maker-novavax-trims-annual-outlook-as-q2-sales-take-a-hit

Novavax reported Q2 2024 revenue of $415 million, missing estimates, with net income rising to $162 million. EPS increased to $...

 novavax-exec-says-updated-covid-vaccine-arriving-in-us-warehouse-this-month-distribution-to-start-after-fda-authorization-expects-more-successful-us-vaccination-season-compared-to-last-year-data-indicates-vaccine-targeting-jn1-should-provide-coverage-for-current-variants

- Conference Call

 novavax-q2-2024-gaap-eps-099-misses-164-estimate-sales-415484m-miss-458575m-estimate

Novavax (NASDAQ:NVAX) reported quarterly earnings of $0.99 per share which missed the analyst consensus estimate of $1.64 by 39...

 b-riley-securities-maintains-buy-on-novavax-lowers-price-target-to-25

B. Riley Securities analyst Mayank Mamtani maintains Novavax (NASDAQ:NVAX) with a Buy and lowers the price target from $29 t...

 whats-going-on-with-novavax-nvax-stock

Novavax shares are trading lower by 5.5% Thursday morning. Shares of several vaccine makers are trading lower after Moderna rev...

 jp-morgan-downgrades-novavax-to-underweight-announces-8-price-target

JP Morgan analyst Eric Joseph downgrades Novavax (NASDAQ:NVAX) from Neutral to Underweight and announces $8 price target.

 whats-going-on-with-novavax-shares-today

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Thursday. Here's what you need to know.

 covid-activity-is-elevated-across-26-states-in-summer-surge-biden-remains-in-isolation-3-vaccine-stocks-to-watch

Over half of US states have high levels of Covid-19 in wastewater as President Biden isolates with virus. New vaccines expected...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION